Skip to Main Content

Author Details

Arnaud Da Cruz Paula
Memorial Sloan Kettering Cancer Center
2014
80
24
PMIDPaper TitleJournal TitlePublished Year
37925055Nonlobular Invasive Breast Carcinomas with Biallelic Pathogenic CDH1 Somatic Alterations: A Histologic, Immunophenotypic, and Genomic Characterization.Mod Pathol2024
38013631Decreased HER2 expression in endometrial cancer following anti-HER2 therapy.J Pathol2024
36007103High-Sensitivity Mutation Analysis of Cell-Free DNA for Disease Monitoring in Endometrial Cancer.Clin Cancer Res2023
37558129HER2 Genetic Intratumor Heterogeneity Is Associated With Resistance to Trastuzumab and Trastuzumab Emtansine Therapy in Recurrent High-Grade Endometrial Cancer.Mod Pathol2023
37587346Long-molecule scars of backup DNA repair in BRCA1- and BRCA2-deficient cancers.Nature2023
37584555Endometrial/Endometrioid Stromal Tumors With Extensive Whorling and CTNNB1 Translocation : A Report of 3 Cases.Am J Surg Pathol2023
37945902Most large structural variants in cancer genomes can be detected without long reads.Nat Genet2023
37651310Molecular Characterization of Endometrial Carcinomas in Black and White Patients Reveals Disparate Drivers with Therapeutic Implications.Cancer Discov2023
37443169Clinicopathologic and genomic features of lobular like invasive mammary carcinoma: is it a distinct entity?NPJ Breast Cancer2023
36617679Ovarian RASoma With Mesonephric-like Adenocarcinoma and Mixed Mullerian Components: A Case Report With Molecular Analysis Demonstrating Multidirectional Mullerian Differentiation.Int J Gynecol Pathol2023
36744932Comprehensive analysis of germline drivers in endometrial cancer.J Natl Cancer Inst2023
36302256Cervical Pleuropulmonary Blastoma-like Tumor Associated With DICER1 and TP53 Mutations.Int J Gynecol Pathol2023
36355783Molecular Characterization of Acquired Resistance to KRASG12C-EGFR Inhibition in Colorectal Cancer.Cancer Discov2023
36323507<i>KIT</i> genetic alterations in breast cancer.J Clin Pathol2023
33148628Neuroendocrine tumours of the breast: a genomic comparison with mucinous breast cancers and neuroendocrine tumours of other anatomic sites.J Clin Pathol2022
35411948Recurrent WWTR1 S89W mutations and Hippo pathway deregulation in clear cell carcinomas of the cervix.J Pathol2022
35443055MAPK Pathway Genetic Alterations Are Associated with Prolonged Overall Survival in Low-Grade Serous Ovarian Carcinoma.Clin Cancer Res2022
35484264Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA.Nat Med2022
35849120Microsatellite Instability-High Endometrial Cancers with MLH1 Promoter Hypermethylation Have Distinct Molecular and Clinical Profiles.Clin Cancer Res2022
36551247Comprehensive Genomic Profiling of Cell-Free Circulating Tumor DNA Detects Response to Ribociclib Plus Letrozole in a Patient with Metastatic Breast Cancer.Biomolecules2022
36517593Ovarian cancer mutational processes drive site-specific immune evasion.Nature2022
36177509Vulvar angiomyofibroblastoma is molecularly defined by recurrent MTG1-CYP2E1 fusions.Histopathology2022
36240474Risk Stratification of Stage I Grade 3 Endometrioid Endometrial Carcinoma in the Era of Molecular Classification.JCO Precis Oncol2022
36289342Single-cell genomic variation induced by mutational processes in cancer.Nature2022
34949653Cancer-Causative Mutations Occurring in Early Embryogenesis.Cancer Discov2022
35175560Granular cell tumor of thyroid: a case series with molecular characterization highlighting unique pitfalls.Endocrine2022
35235413Same-Cell Co-Occurrence of RAS Hotspot and BRAF V600E Mutations in Treatment-Naive Colorectal Cancer.JCO Precis Oncol2022
34961764ESR1 hotspot mutations in endometrial stromal sarcoma with high-grade transformation and endocrine treatment.Mod Pathol2022
35292180Hyperthermic intraperitoneal chemotherapy (HIPEC) with carboplatin induces distinct transcriptomic changes in ovarian tumor and normal tissues.Gynecol Oncol2022
34599282The clinical behavior and genomic features of the so-called adenoid cystic carcinomas of the solid variant with basaloid features.Mod Pathol2022
34561551TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibition.Mod Pathol2022
33376197Stromal <i>MED12</i> exon 2 mutations in complex fibroadenomas of the breast.J Clin Pathol2022
33021035The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas.Mol Oncol2021
33622519Genetic and molecular subtype heterogeneity in newly diagnosed early- and advanced-stage endometrial cancer.Gynecol Oncol2021
33534223A Distinctive Adnexal (Usually Paratubal) Neoplasm Often Associated With Peutz-Jeghers Syndrome and Characterized by STK11 Alterations (STK11 Adnexal Tumor): A Report of 22 Cases.Am J Surg Pathol2021
33893322Genetic interactions among Brca1, Brca2, Palb2, and Trp53 in mammary tumor development.NPJ Breast Cancer2021
33863915TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer.NPJ Breast Cancer2021
33527450Genetic characterisation of adult primary pleomorphic uterine rhabdomyosarcoma and comparison with uterine carcinosarcoma.Histopathology2021
33772212Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases.Mod Pathol2021
34759319Diverse alterations associated with resistance to KRAS(G12C) inhibition.Nature2021
34568720Spectrum of <i>BRAF</i> Mutations and Gene Rearrangements in Ovarian Serous Carcinoma.JCO Precis Oncol2021
34446268Diagnosis and management of an endometrial cancer patient with Cowden syndrome.Gynecol Oncol2021
33328602Clonal relationship and directionality of progression of synchronous endometrial and ovarian carcinomas in patients with DNA mismatch repair-deficiency associated syndromes.Mod Pathol2021
33263939Whole-exome sequencing analysis of juvenile papillomatosis and coexisting breast carcinoma.J Pathol Clin Res2021
31492931Histologic spectrum of polymorphous adenocarcinoma of the salivary gland harbor genetic alterations affecting PRKD genes.Mod Pathol2020
31757464Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer.Gynecol Oncol2020
31932695ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer.Nat Genet2020
31896809Immunohistochemical analysis of IDH2 R172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarity.Mod Pathol2020
31896750Identification of recurrent FHL2-GLI2 oncogenic fusion in sclerosing stromal tumors of the ovary.Nat Commun2020
31801397Molecular Characterization of a Rare Dedifferentiated Liposarcoma With Rhabdomyosarcomatous Differentiation in a 24 Year Old.Int J Surg Pathol2020
  • 1 - 50 of 80

Recommended Authors

Tayyebeh M Nazeran
University of British Columbia
Career Start Year 2016
Number of shared co-authors 3
Amy Lum
University of British Columbia
Career Start Year 2014
Number of shared co-authors 2
Joanna Cyrta
Paris Sciences Lettres University PSL, Institut CURIE
Career Start Year 2012
Number of shared co-authors 14
Dan R Robinson
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2011
Number of shared co-authors 11
Gunes Gundem
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 14
Anne-Sophie Sertier
Synergie Lyon Cancer Foundation
Career Start Year 2009
Number of shared co-authors 3
Francine B de Abreu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 0
Anna M Piskorz
CRUK Cambridge Institute, University of Cambridge
Career Start Year 2007
Number of shared co-authors 5
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 20
Joshy George
Peter MacCallum Cancer Centre
Career Start Year 2005
Number of shared co-authors 3
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 6
Andrew H Beck
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 2004
Number of shared co-authors 6
Leah M Prentice
British Columbia Women's Hospital and Health Centre
Career Start Year 2004
Number of shared co-authors 6
Michael S Anglesio
University of British Columbia
Career Start Year 2004
Number of shared co-authors 7
Katherine A Hoadley
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Career Start Year 2004
Number of shared co-authors 11
Peter T Simpson
UQ Centre for Clinical Research, The University of Queensland
Career Start Year 2003
Number of shared co-authors 4
Sherri Z Millis
Foundation Medicine Inc
Career Start Year 2003
Number of shared co-authors 3
Siddhartha Deb
Olivia Newton-John Cancer Research Institute
Career Start Year 2002
Number of shared co-authors 1
Maryou B Lambros
The Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 10
Kenna R Mills Shaw
The University of Texas MD Anderson Cancer Center
Career Start Year 1999
Number of shared co-authors 4
Jonathan K Killian
From Foundation Medicine
Career Start Year 1999
Number of shared co-authors 1
Dirce Maria Carraro
AC Camargo Cancer Center
Career Start Year 1998
Number of shared co-authors 1
Ingrid Hedenfalk
Lund University and Skane University Hospital
Career Start Year 1997
Number of shared co-authors 1
James D Brenton
CRUK Cambridge Institute, University of Cambridge
Career Start Year 1995
Number of shared co-authors 12
Janine Senz
University of British Columbia
Career Start Year 1994
Number of shared co-authors 7
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 10
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 13
Sunil R Lakhani
University of Queensland
Career Start Year 1983
Number of shared co-authors 7
Jos?? Palacios
Universidad de Alcala
Career Start Year 1983
Number of shared co-authors 10
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 10

Collaborators

Britta Weigelt
Memorial Sloan Kettering Cancer Center
Co-authored papers 72
Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Co-authored papers 55
Pier Selenica
Memorial Sloan Kettering Cancer Center
Co-authored papers 30
Hannah Y Wen
Memorial Sloan Kettering Cancer Center
Co-authored papers 20
David N Brown
Memorial Sloan Kettering Cancer Center
Co-authored papers 18
Robert A Soslow
Co-authored papers 13
Larry Norton
Memorial Sloan Kettering Cancer Center
Co-authored papers 9
Lora H Ellenson
Memorial Sloan Kettering Cancer Center
Co-authored papers 9
Brian P Rubin
Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic
Co-authored papers 8
Salvatore Piscuoglio
University of Basel
Co-authored papers 7
Nadeem Riaz
Memorial Sloan Kettering Cancer Center
Co-authored papers 7
Caterina Marchi??
University of Turin, Candiolo Cancer Institute, FPO-IRCCS
Co-authored papers 7
Charlotte K Y Ng
University of Bern
Co-authored papers 6
Rahul Kumar
Roswell Park Comprehensive Cancer Center
Co-authored papers 6
Felipe C Geyer
Instituto Do Cancer Do Estado de Sao Paulo
Co-authored papers 6
Michael F Berger
Co-authored papers 6
Luciano G Martelotto
Monash University
Co-authored papers 6
Juan P Palazzo
Thomas Jefferson University Hospital
Co-authored papers 4
Xin Pei
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Nicola Fusco
IEO European Institute of Oncology IRCCS
Co-authored papers 4
Ronglai Shen
Co-authored papers 3
Francisco Beca
Stanford University School of Medicine
Co-authored papers 3
Ilan Weinreb
University Health Network
Co-authored papers 3
Elisa de Stanchina
Co-authored papers 3
Nora Katabi
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Gabriele Zoppoli
University of Genoa and Ospedale Policlinico San Martino
Co-authored papers 2
José Baselga
Co-authored papers 2
Raja R Seethala
University of Pittsburgh Medical Center-Presbyterian
Co-authored papers 2
Michael F Walsh
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Alena Sk??lov??
Charles University
Co-authored papers 2
Release 1.2